Antibiotic innovation may contribute to slowing the dissemination of multiresistant Streptococcus pneumoniae: the example of ketolides.
<h4>Background</h4>Despite increasingly frequent bacterial resistance to antibiotics, antibacterial innovation is rare. Ketolides constitute one of the very few new antibiotic classes active against Streptococcus pneumoniae developed during the last 25 years. Their mechanism of action re...
Guardado en:
Autores principales: | Lulla Opatowski, Laura Temime, Emmanuelle Varon, Roland Leclercq, Henri Drugeon, Pierre-Yves Boëlle, Didier Guillemot |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2008
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2e3931a74f424d8d8dafe94300707f55 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Structural and mechanistic basis for translation inhibition by macrolide and ketolide antibiotics
por: Bertrand Beckert, et al.
Publicado: (2021) -
Assessing the role of inter-facility patient transfer in the spread of carbapenemase-producing Enterobacteriaceae: the case of France between 2012 and 2015
por: Narimane Nekkab, et al.
Publicado: (2020) -
Skin tolerant inactivation of multiresistant pathogens using far-UVC LEDs
por: Johannes Glaab, et al.
Publicado: (2021) -
The Leader Peptide peTrpL Forms Antibiotic-Containing Ribonucleoprotein Complexes for Posttranscriptional Regulation of Multiresistance Genes
por: Hendrik Melior, et al.
Publicado: (2020) -
Betamethasone inhibits tumor development, microvessel density and prolongs survival in mice with a multiresistant adenocarcinoma TA3
por: Garrido,Osvaldo, et al.
Publicado: (2010)